NCT00552760View on ClinicalTrials.gov

Ramelteon for the Treatment of Insomnia and Mood Stability in Patients With Euthymic Bipolar Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

March 31, 2010

Study Completion Date

May 31, 2010

Conditions
Bipolar Disorder
Interventions
DRUG

Ramelteon

one 8 mg tablet at bedtime for up to 6 months

DRUG

Placebo

one tablet at bedtime for up to 6 months

Trial Locations (1)

18103

Lehigh Valley Hospital, Department of Psychiatry, Allentown

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

Lehigh Valley Hospital

OTHER

NCT00552760 - Ramelteon for the Treatment of Insomnia and Mood Stability in Patients With Euthymic Bipolar Disorder | Biotech Hunter | Biotech Hunter